EquityZen Growth Technology Fund LLC - Series 298
Raised
$130K
Investors
8
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 298 is a Delaware-domiciled pooled investment vehicle filed by EquityZen Advisors LLC on 2018-10-03, raising $130K from 8 investors under Rule 506(b) and 3(c)(1) exemptions with a $10K minimum investment. This is part of the EquityZen platform, which operates 1,891 related EDGAR entities providing pre-IPO secondary market access through individual series vehicles.
This pre-IPO fund follows a standard 506(b)/3(c)(1) private placement structure typical of secondary market access vehicles. The $10K minimum positions it at the lower end of alternative investment accessibility, consistent with EquityZen's retail-accredited investor model for fractional pre-IPO exposure.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.